Artificial Intelligence 2021 - FDA Regulation of Artificial Intelligence/ Machine Learning
Topics/Call fo Papers
Artificial Intelligence/ Machine Learning (AI/ML) will revolutionize medicine by making diagnosis and treatment more accessible and more effective. FDA has regulated medical software by means of regulation and guidances for years
This 60-minute accredited online training will address the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future.
Speaker:
Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control
This 60-minute accredited online training will address the current regulatory requirements, how they don’t control AI/ML adequately, and approaches FDA is considering for regulation in the near future.
Speaker:
Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control
Other CFPs
Last modified: 2021-01-07 22:29:51